BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28994899)

  • 21. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
    Dastgiri S; Dolatkhah R
    Cochrane Database Syst Rev; 2016 Aug; (8):CD007843. PubMed ID: 27574910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laser therapy for retinopathy in sickle cell disease.
    Myint KT; Sahoo S; Thein AW; Moe S; Ni H
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010790. PubMed ID: 26451693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD001912. PubMed ID: 25419599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc supplements for treating thalassaemia and sickle cell disease.
    Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
    Dolatkhah R; Dastgiri S
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007843. PubMed ID: 31942751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009191. PubMed ID: 34932828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009191. PubMed ID: 26041152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatments for priapism in boys and men with sickle cell disease.
    Chinegwundoh FI; Smith S; Anie KA
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004198. PubMed ID: 32251534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.
    Robinson KA; Odelola OA; Saldanha IJ
    Cochrane Database Syst Rev; 2014 May; (5):CD007743. PubMed ID: 24851825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.